Dr. Reddy's Laboratories Limited ( RDY) - Stock Earnings
RDY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 23, 2026 BeforeMarket | — / — | — | — / — | — |
RDY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 134.6 million USD | 970.9 million USD |
| 2026Q1 | 23.8 million USD | 811.5 million USD |
| 2026Q2 | 47.0 million USD | 855.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RDY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 668.0 million USD | 3.3 billion USD |
| 2025 | 661.0 million USD | 3.8 billion USD |
| 2026 | 479.3 million USD | 3.8 billion USD |
| 2026 Est. | — | — |
RDY
Price: $12.48
Dividend Yield: 0.68%
Forward Dividend Yield: 0.67%
Payout Ratio: 24.14%
Dividend Per Share: 0.08 USD
Earnings Per Share: 0.41 USD
P/E Ratio: 28.71
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: India
Volume: 129000
Ebitda: 142.4 millionMarket Capitalization: 10.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: -8.82%
DGR5: 30.00%
DGR10: 30.00%